© 2025 WGCU News
PBS and NPR for Southwest Florida
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

RFK Jr. plans to keep a financial stake in lawsuits against the drugmaker Merck

RFK Jr. made $856,559 in referral fees from the law firm Wisner Baum, which is suing Merck over claims its HPV vaccine caused cervical cancer, according to new filings with the Office of Government Ethics.
Bloomberg
/
Getty Images
RFK Jr. made $856,559 in referral fees from the law firm Wisner Baum, which is suing Merck over claims its HPV vaccine caused cervical cancer, according to new filings with the Office of Government Ethics.

Even if Robert F. Kennedy Jr. is confirmed as the next Health and Human Services secretary, he still plans to collect fees from Wisner Baum, a law firm suing Merck over claims that the pharmaceutical company failed to properly warn consumers about risks from its HPV vaccine, Gardasil, according to new filings with the Office of Government Ethics.

Kennedy will only collect the fees if Wisner Baum wins, and only for cases that aren't against the United States or in which the United States isn't a party and doesn't have "a direct or substantial interest," according to the filings.

"Pursuant to the referral agreement, I am entitled to receive 10% of fees awarded in contingency fee cases referred to the firm," Kennedy wrote in his signed ethics agreement. "I am not trying these cases, I am not an attorney of record for the cases, and I will not provide representational services in connection with the cases during my appointment to the position of Secretary."

The filings, submitted to the U.S. Office of Government Ethics as part of the confirmation process, detail Kennedy's many financial holdings and interests. If he becomes HHS secretary and continues to collect fees, he would be in a position to potentially profit from vaccine litigation while also regulating drugmakers and exercising authority over federal vaccine policy.

"RFK Jr's ethics agreement is inadequate because it doesn't address the bias created by his continuing financial interest in the litigation against Merck," Kathleen Clark, a law professor at Washington University in St. Louis who specializes in government ethics wrote to NPR.

Neither a spokeswoman for Kennedy nor the Trump transition team immediately returned repeated requests for comment.

The documents and their link to the Gardasil vaccine lawsuit were first reported by The New York Times.

The Senate Finance Committee has scheduled a hearing on Wednesday, Jan. 29, to consider Kennedy's nomination to run HHS.

In Kennedy's profile page on Wisner Baum's website, he is first identified as "co-counsel with Wisner Baum in the Gardasil litigation," and he has used his platforms on social media and through his nonprofit to promote the suit and his concerns with the vaccine against the human papillomavirus.

HPV is a very common sexually transmitted virus that can cause cancers later in life. The Centers for Disease Control and Prevention recommends two doses of HPV vaccine at ages 11 to 12 and says it provides safe, effective and lasting protection against HPV infections.

According to Kennedy's personal financial disclosure report, he made $856,559 in referral fees from the law firm. That's in addition to $326,056 in salary and benefits he earned from the nonprofit Children's Health Defense, an organization Kennedy chaired and that has been influential in the anti-vaccine movement. The nonprofit has filed nearly 30 federal and state lawsuits since 2020, including some that target the federal agencies he would oversee at HHS. Many of the legal actions taken by CHD challenged vaccines and public health mandates.

The filing says Kennedy took an unpaid leave of absence from the organization in April 2023, when he declared his run for the presidency, and that he resigned from CHD effective December 2024.

The filing also shows Kennedy declared a $8,848,402 share of partnership profits from the law firm Kennedy and Madonna, LLP, which has been renamed Madonna and Madonna, LLP. The filing says he received his "final partnership payout in May 2024." He also made money from another law firm, publishing and various other fees for speaking and endorsements.

Edited by Scott Hensley and Jane Greenhalgh

Copyright 2025 NPR

Sydney Lupkin is the pharmaceuticals correspondent for NPR.
Trusted by over 30,000 local subscribers

Local News, Right Sized for Your Morning

Quick briefs when you are busy, deeper explainers when it matters, delivered early morning and curated by WGCU editors.

  • Environment
  • Local politics
  • Health
  • And more

Free and local. No spam. Unsubscribe anytime.

More from WGCU
  • March Madness has come early to Florida Gulf Coast University, as anticipation builds for the return of the Men’s and Women’s Basketball Team.
  • Florida is the land of sunshine and good vibes, but when the sun goes down on Downtown Fort Myers, something ghastly takes over. The waterside community is home to spiritual abnormalities that have caused spine-tingling reactions for decades.WGCU’s Samuel Brucker took part in a Historic Downtown Tour to learn the horrific stories that have turned into urban legend and have given a taste of the macabre to Southwest Florida.
  • Adult Thorn Bugs are half-inch long insects that are “true bugs” (members of the insect Family Membracidae). They are native to South America, Central America, and many tropical islands. As with other members of this family, Thorn Bugs have sucking mouthparts that allow them to pierce plant tissues and drink plant sap. As a result, Thorn Bugs can cause the death of some twigs and potentially introduce diseases to the plant. However, in most cases, Thorn Bug populations are very low and damage caused by thorn bugs is minimal. The good news is that these insects do not feed on most native North American trees. Thorn bugs are an exotic invasive species in Florida that was likely introduced long ago along with an exotic tree species such as the Earleaf Acacia.Even today these insects feed primarily on exotic invasive trees and shrubs imported from tropical areas.